Lenacapavir Sodium

ATC J05AX31 · 3 markets · 9 records

Lenacapavir Sodium 3 markets · 9 records Forms
Filters
MarketAU 5SG 2FR 2

AU 5 records · 2 shown of 2 Source TGA · Data as of 2026-10-28 · includes records with unknown status (not proof of sale)

  • 306.8 mgtabletSUNLENCA lenacapavir (as sodium) 300 mg film coated tablet blister packSUNLENCA lenacapavir (as sodium) 300 mg film coated tablet bottle、YEYTUO lenacapavir (as sodium) 300 mg tablet bottle unknown
  • 473.1 mginjectionSUNLENCA lenacapavir (as sodium) 463.5 mg/1.5 mL solution for injection vialYEYTUO lenacapavir (as sodium) 463.5 mg/1.5 mL solution for injection vial unknown

SG 2 records · 2 shown of 2 Source Health Sciences Authority (HSA) · Data as of 2026-08-07

FR 2 records · 2 shown of 2 Source Base de données publique des médic · Data as of 2026-11-03

  • 300 mgtabletSUNLENCA 300 mg, comprimé pelliculé also in SG
  • 464 mginjectionSUNLENCA 464 mg, solution injectable
The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.